IGF1 and cancer: At high concentrations, NDGA disrupts the activation of ERK and AKT signaling pathways activated by IGF-I (insulin-like growth factor-1) and induces apoptosis (Meyer et al., 2007), the effect being highly important for cancer treatment but also for unwanted side-effects.